{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:06:18Z","timestamp":1766390778351,"version":"3.40.5"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,1,1]]},"abstract":"<jats:p>Objectives.\u2003To report the outcome of intervention to reduce early-onset group B streptococcal disease (EOGBSD) at a tertiary maternity hospital in Sydney and to review all cases of EOGBSD since intervention to improve outcomes further.<\/jats:p><jats:p>Methodology.\u2003A prospective study was made of all cases of EOGBSD in the 16 months before and 8 years after an intervention that comprised universal screening and intrapartum ampicillin for all maternal carriers of group B streptococcus. Carriers were detected by screening all women at 28 weeks, or 24 weeks with known risk factors for preterm birth, by low vaginal swab, cultured onto blood agar and treated with intravenous ampicillin in labor, 1 g every 6 hours until delivery. Women with a routine midstream urine test positive for group B streptococcus, a previous neonate with EOGBSD, or preterm labor with an unknown carrier status were also treated. EOGBSD was detected by screening all neonates with maternal and\/or neonatal risk factors for sepsis.<\/jats:p><jats:p>Results.\u2003The incidence of blood culture-positive EOGBSD for all live births before intervention was 1.4 per 1000 compared with a rate after intervention of 0.2 per 1000 live births. The incidence, if there were clinical signs of infection and the urine tested positive for streptococcal antigen, decreased from 3.5 per 1000 before intervention to 0.6 per 1000 live births. There was a statistically significant reduction in neonatal morbidity outcomes after intervention, including requirement for admission and treatment in a neonatal unit and the need for ventilation. An audit indicated that by the 8th year, 90% of all pregnant women were screened by a low vaginal swab at 28 weeks and 10.5% were carriers. After intervention, of the 28 neonates with EOGBSD, 64% were associated with departure from the protocol.<\/jats:p><jats:p>Conclusion.\u2003The intervention has coincided with a significant decrease in the incidence of blood culture-positive EOGBSD to 0.2 and urine streptococcal antigen-positive disease to 0.6 per 1000 live births. The 84% reduction in EOGBSD has been obtained by treating 244 neonates in labor to prevent disease in one neonate. Additional reduction seems possible by improving the compliance by staff with the protocol. By contrast, before intervention and in maternity units throughout Australia with no intervention, the rates for EOGBSD remain largely unchanged at \u223c2 per 1000 live births.<\/jats:p>","DOI":"10.1542\/peds.101.1.e2","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:44:32Z","timestamp":1092440672000},"page":"e2-e2","source":"Crossref","is-referenced-by-count":47,"title":["Eight-Year Outcome of Universal Screening and Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers"],"prefix":"10.1542","volume":"101","author":[{"given":"Heather E.","family":"Jeffery","sequence":"first","affiliation":[{"name":"1 From the Department of Neonatal Medicine, King George V Hospital, and the University of Sydney, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Moses Lahra","sequence":"additional","affiliation":[{"name":"1 From the Department of Neonatal Medicine, King George V Hospital, and the University of Sydney, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1998,1,1]]},"reference":[{"key":"2021120904455908000_B1","first-page":"25","article-title":"Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system.","volume":"41","author":"Zangwill","year":"1992","journal-title":"MMWR."},{"key":"2021120904455908000_B2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1651-2227.1990.tb11378.x","article-title":"Incidence and etiology of neonatal septicemia and meningitis in Western Sweden 1975\u20131986.","volume":"79","author":"Tessin","year":"1990","journal-title":"Acta Paediatr Scand."},{"key":"2021120904455908000_B3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1651-2227.1989.tb10885.x","article-title":"Neonatal septicaemia in Finland 1981\u20131985.","volume":"78","author":"Vesikari","year":"1989","journal-title":"Acta Paediatr Scand."},{"key":"2021120904455908000_B4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5694\/j.1326-5377.1995.tb124596.x","article-title":"Early-onset group B streptococcal infections in Aboriginal and non-Aboriginal infants.","volume":"163","author":"Australasian Study Group for Neonatal Infections","year":"1995","journal-title":"Med J Aust."},{"key":"2021120904455908000_B5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1542\/peds.93.5.814","article-title":"Infant sleep position and risk for sudden infant death syndrome.","volume":"93","author":"Willinger","year":"1994","journal-title":"Pediatrics."},{"key":"2021120904455908000_B6","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: a public health perspective.","volume":"45","author":"US Department of Health and Human Services, Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR."},{"key":"2021120904455908000_B7"},{"key":"2021120904455908000_B8","first-page":"77","article-title":"Perinatal group B streptococcal infections: a significant public health problem.","volume":"1","author":"Jeffery","year":"1996","journal-title":"Semin Neonatol Fetal Neonatal Infect."},{"key":"2021120904455908000_B9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1479-828X.1995.tb01853.x","article-title":"Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate?","volume":"35","author":"Gilbert","year":"1995","journal-title":"Aust N Z Obstet Gynaecol."},{"key":"2021120904455908000_B10"},{"key":"2021120904455908000_B11","first-page":"1659","article-title":"Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis.","volume":"149","author":"Allen","year":"1993","journal-title":"Can Med Assoc J."},{"key":"2021120904455908000_B12","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0002-9378(94)70307-8","article-title":"Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials.","volume":"170","author":"Ohlsson","year":"1994","journal-title":"Am J Obstet Gynecol."},{"key":"2021120904455908000_B13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3476(87)80283-4","article-title":"Group B streptococcal carriage and disease a 6-year prospective study.","volume":"110","author":"Dillon","year":"1987","journal-title":"J Pediatr."},{"key":"2021120904455908000_B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1479-828X.1994.tb01031.x","article-title":"Antepartum screening and non-selective intrapartum chemoprophylaxis for group B streptococcus.","volume":"34","author":"Jeffery","year":"1994","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"2021120904455908000_B15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/adc.67.10_Spec_No.1198","article-title":"Clinical application of urine antigen detection in early onset group B streptococcal disease.","volume":"67","author":"McIntosh","year":"1992","journal-title":"Arch Dis Child."},{"key":"2021120904455908000_B16","first-page":"309","article-title":"Examination of the placenta.","volume":"18","author":"Benirshke","year":"1961","journal-title":"Obstet Gynecol."},{"key":"2021120904455908000_B17","first-page":"127","article-title":"Inflammatory lesions of the human placenta. I.","volume":"1","author":"Russell","year":"1979","journal-title":"Am J Diagn Gynecol Obstet."},{"key":"2021120904455908000_B18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/adc.65.2.207","article-title":"Neonatal pneumonia.","volume":"65","author":"Webber","year":"1990","journal-title":"Arch Dis Child."},{"key":"2021120904455908000_B19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198606263142603","article-title":"Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.","volume":"314","author":"Boyer","year":"1986","journal-title":"N Engl J Med."},{"key":"2021120904455908000_B20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5694\/j.1326-5377.1995.tb126024.x","article-title":"Systemic bacterial and fungal infections in infants in Australian neonatal units.","volume":"162","author":"Isaacs","year":"1995","journal-title":"Med J Aust."},{"key":"2021120904455908000_B21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1479-828X.1991.tb01797.x","article-title":"Group B streptococcus and neonatal infections: the case for intrapartum chemoprophylaxis.","volume":"31","author":"Garland","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"2021120904455908000_B22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9378(94)70221-7","article-title":"Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment.","volume":"170","author":"Katz","year":"1994","journal-title":"Am J Obstet Gynecol."},{"key":"2021120904455908000_B23","first-page":"496","article-title":"Neonatal group B streptococcal sepsis during 2 years of a universal screening program.","volume":"84","author":"Gibbs","year":"1994","journal-title":"Obstet Gynecol."},{"key":"2021120904455908000_B24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1542\/peds.93.4.631","article-title":"Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.","volume":"93","author":"Pylipow","year":"1994","journal-title":"Pediatrics."},{"key":"2021120904455908000_B25"},{"key":"2021120904455908000_B26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00006254-199108000-00001","article-title":"Group B streptococcus: the effectiveness of screening and chemoprophylaxis.","volume":"46","author":"Greenspoon","year":"1991","journal-title":"Obstet Gynecol Surv."},{"key":"2021120904455908000_B27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/infdis\/148.5.802","article-title":"Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.","volume":"148","author":"Boyer","year":"1983","journal-title":"J Infect Dis."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/101\/1\/e2\/823493\/e2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/101\/1\/e2\/823493\/e2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:34:02Z","timestamp":1682746442000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/101\/1\/e2\/52284\/Eight-Year-Outcome-of-Universal-Screening-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1998,1,1]]},"published-print":{"date-parts":[[1998,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.101.1.e2","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"type":"electronic","value":"1098-4275"},{"type":"print","value":"0031-4005"}],"subject":[],"published":{"date-parts":[[1998,1,1]]}}}